# Viusid Administration in Subjects With Chronic Inflammatory Syndrome Under Hemodialysis Treatment

> **NCT00978224** · PHASE3 · SUSPENDED · sponsor: **Catalysis SL** · enrollment: 152 (estimated)

## Conditions studied

- Chronic Inflammatory Syndrome

## Interventions

- **DIETARY_SUPPLEMENT:** Viusid
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT00978224
- **Lead sponsor:** Catalysis SL
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2009-10
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 152 (ESTIMATED)
- **Why stopped:** Decision of the investigator
- **Last updated:** 2010-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00978224

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00978224, "Viusid Administration in Subjects With Chronic Inflammatory Syndrome Under Hemodialysis Treatment". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00978224. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*